J. M. Zuñiga

Learn More
We have the tools at our disposal to significantly bend AIDS-related morbidity and mortality curves and reduce human immunodeficiency virus (HIV) incidence. It is thus essential to redouble our efforts to reach the goal of placing 15 million people on life-saving and -enhancing antiretroviral therapy (ART) by 2015. In reaching this milestone, we can write a(More)
BACKGROUND Little is known globally about the perspectives of people living with HIV/AIDS (PLWHA) on perceived HIV-related stigma and its consequences. METHODS Cross-sectional study (January-March 2010) of perceived HIV-related stigma among PLWHA (N = 2035) using a standardized questionnaire. FINDINGS Thirty-seven percent of respondents reported(More)
BACKGROUND Little is known about patients' health literacy regarding antiretroviral therapy (ART) adherence and drug resistance and patient-provider communication about these topics. DESIGN AND METHODS The AIDS Treatment for Life International Survey was a multicountry cross-sectional study (January-March 2010) including 2035 HIV-infected adults. A(More)
BACKGROUND Splenic abscesses are uncommon, appear in subjects with predisposing factors such as systemic infections and have high mortality rates. AIM To report seven patients with splenic abscesses. MATERIAL AND METHODS Retrospective review of medical records of patients with a splenic abscess treated between 1987 and 2005. RESULTS The records of(More)
The International Association of Physicians in AIDS Care (IAPAC) represents more than 12 000 physicians and allied health care providers in over 100 countries who are daily caring for and providing support to men, women, and children living with HIV/AIDS. In addition, IAPAC advances advocacy, education, and technical assistance activities in the United(More)
BACKGROUND Antiretroviral therapy (ART) has reached millions of HIV-infected patients worldwide, however very little is known about their perceptions about HIV disease and its treatment. The AIDS Treatment for Life International Survey (ATLIS) is the largest sampling of patient perceptions about HIV disease and its treatment, as well as their behaviors,(More)
In the context of emerging evidence related to preexposure prophylaxis and HIV treatment as prevention, an evidence summit was held in mid-2012 to discuss the current state of the science and to provide a platform for consensus building around whether and how these prevention strategies might be implemented globally. Health care providers, researchers,(More)
High, persistent levels of antiretroviral therapy (ART) adherence are generally required to achieve sustained virologic suppression. Recently published global guidelines on entry into and retention in care and ART adherence include recommendations for monitoring and supporting ART adherence as a standard part of HIV clinical management. Several tools to(More)